- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Moderna picks drugmaker Catalent to manufacture potential COVID-19 vaccine
Jun 25, 2020
Tocotrienol Market Estimated to Expand at a Robust CAGR over 2020-2027
Mar 15, 2021
Sanofi says COVID-19 vaccine will be available globally at the same time
May 15, 2020
Geneyork Pharmaceutical Announces U.S. Launch of Generic Version of Deltasone® (Prednisone) Tablets
Feb 03, 2020
Emerging nations represent an excellent opportunity for the pharmaceutical industry to develop anti-fungal drugs
Sep 24, 2019
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Mar 26, 2020
Radioactive Tracer Market is expected to reach US$ 54,296.57 million by 2030
Aug 11, 2023